MELISSA RIEDINGER: Open Payments
NPI 1134512163 · SILSBEE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 37 payments from 13 companies in 2025. Trend: 2023 $451 · 2024 $758 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $411 |
| Axsome Therapeutics, Inc. | 6 | $135 |
| Novo Nordisk Inc | 2 | $102 |
| AstraZeneca Pharmaceuticals LP | 2 | $83 |
| Otsuka America Pharmaceutical, Inc. | 1 | $82 |
| Teva Pharmaceuticals USA, Inc. | 1 | $74 |
| Lilly USA, LLC | 2 | $37 |
| GENZYME CORPORATION | 1 | $31 |
| PFIZER INC. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: VRAYLAR, Auvelity, Ozempic, BREZTRI, REXULTI, UBRELVY, AUSTEDO XR, MOUNJARO.
Industry payments across TX — which companies pay providers there.
